Published in J Mol Cell Cardiol on August 03, 2013
Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature (2015) 2.51
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis. Cell Death Dis (2015) 0.99
Adrenergic signaling in heart failure: a balance of toxic and protective effects. Pflugers Arch (2014) 0.94
Biased β2 -adrenoceptor signalling in heart failure: pathophysiology and drug discovery. Br J Pharmacol (2014) 0.82
Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent. Circ Res (2017) 0.80
Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. J Dent Res (2014) 0.76
A New Pathway for Sympathetic Cardioprotection in Heart Failure. Circ Res (2015) 0.76
β 1 Adrenoceptor antagonistic effects of the supposedly selective β 2 adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts. Pharmacol Res Perspect (2015) 0.75
Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy. Ann Transl Med (2016) 0.75
MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy. Nat Commun (2016) 0.75
Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment. J Card Fail (2016) 0.75
Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation. Circulation (2014) 0.75
The Molecular Apgar Score: A Key to Unlocking Evolutionary Principles. Front Pediatr (2017) 0.75
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell (2000) 10.25
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science (1994) 4.84
The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature (2007) 4.63
Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation (2000) 3.85
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol (2009) 3.55
Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol (2000) 3.32
Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest (2003) 3.15
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A (1999) 3.13
The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res (2000) 2.99
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation (1998) 2.91
Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol (2007) 2.90
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A (1998) 2.76
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. Circulation (1999) 2.50
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab (2003) 2.42
Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem (1999) 2.28
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest (2002) 2.26
Crosstalk of beta-adrenergic receptor subtypes through Gi blunts beta-adrenergic stimulation of L-type Ca2+ channels in canine heart failure. Circ Res (2005) 2.11
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci U S A (1996) 2.02
Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol (2001) 1.90
Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation (2000) 1.73
Loss of beta-adrenoceptor response in myocytes overexpressing the Na+/Ca(2+)-exchanger. J Mol Cell Cardiol (2004) 1.68
Beta-adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol (2009) 1.65
Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation (2000) 1.53
Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation (2004) 1.53
Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease. Am J Physiol (1997) 1.50
G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem (1999) 1.49
Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics (2004) 1.44
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest (2001) 1.37
Increase in myocardial Gi-proteins in heart failure. Lancet (1988) 1.33
Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit Care Med (2004) 1.28
The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends Cell Biol (2004) 1.26
Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors. Proc Natl Acad Sci U S A (2003) 1.22
Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol (2005) 1.21
Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes. Am J Physiol Heart Circ Physiol (2002) 1.20
Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev (2005) 1.20
Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. J Pharmacol Exp Ther (2008) 1.20
The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res (2005) 1.15
The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J (2005) 1.13
Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation (1997) 1.05
Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. Cardiovasc Res (1998) 1.03
Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest (1992) 1.01
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways. J Mol Cell Cardiol (2011) 0.85
Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. J Mol Cell Cardiol (2006) 0.85
Ratio imaging: measuring intracellular Ca++ and pH in living cells. Methods Cell Biol (2003) 0.83
A phylogenomic study of birds reveals their evolutionary history. Science (2008) 9.00
Ras and Rap control AMPA receptor trafficking during synaptic plasticity. Cell (2002) 4.50
Prevention of pediatric graft coronary artery disease: atorvastatin. Pediatr Transplant (2008) 2.79
Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 2.72
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest (2008) 2.71
Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation (2007) 2.60
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res (2005) 2.24
Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case. Mol Genet Metab (2010) 2.23
In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol (2011) 1.80
The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest (2013) 1.65
International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant (2004) 1.59
Loss of adenomatous poliposis coli-α3 integrin interaction promotes endothelial apoptosis in mice and humans. Circ Res (2012) 1.56
Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics (2004) 1.44
Variability of characteristics and outcomes following cardiopulmonary resuscitation events in diverse ICU settings in a single, tertiary care children's hospital*. Pediatr Crit Care Med (2014) 1.39
Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res (2005) 1.37
Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol (2009) 1.34
Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant (2010) 1.31
Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation (2006) 1.24
Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med (2004) 1.23
Phylogenomic evidence for multiple losses of flight in ratite birds. Proc Natl Acad Sci U S A (2008) 1.23
Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol (2005) 1.21
Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses. J Mol Cell Cardiol (2004) 1.21
Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol (2008) 1.14
The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J (2005) 1.13
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol (2002) 1.12
RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. J Pharmacol Exp Ther (2012) 1.09
Are transposable element insertions homoplasy free?: an examination using the avian tree of life. Syst Biol (2011) 1.08
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Nat Cell Biol (2013) 1.07
Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction. Circ Cardiovasc Imaging (2008) 1.06
Smooth muscle protein 22alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling. Circ Res (2007) 1.06
Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics (2012) 1.05
Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation (2008) 1.03
Phylogeny and biogeography of the core babblers (Aves: Timaliidae). Syst Biol (2012) 1.02
Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant (2004) 1.00
A well-tested set of primers to amplify regions spread across the avian genome. Mol Phylogenet Evol (2008) 0.99
MFG-E8 activates proliferation of vascular smooth muscle cells via integrin signaling. Aging Cell (2012) 0.99
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy. J Mol Cell Cardiol (2011) 0.99
CuO-promoted construction of N-2-aryl-substituted-1,2,3-triazoles via azide-chalcone oxidative cycloaddition and post-triazole arylation. Org Lett (2011) 0.97
Renal function and genetic polymorphisms in pediatric heart transplant recipients. J Heart Lung Transplant (2012) 0.96
Effect of targeted deletions of beta1- and beta2-adrenergic-receptor subtypes on heart rate variability. Am J Physiol Heart Circ Physiol (2005) 0.96
Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol (2012) 0.96
Familial cardiac valvulopathy due to filamin A mutation. Am J Med Genet A (2011) 0.93
Genomic profiling of left and right ventricular hypertrophy in congenital heart disease. J Card Fail (2008) 0.93
Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha ) is required for hepatocyte-specific expression of factor XI. J Biol Chem (2002) 0.92
RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum Genet (2007) 0.92
Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol (2011) 0.91
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Arthritis Res Ther (2013) 0.90
Iduna protects HT22 cells from hydrogen peroxide-induced oxidative stress through interfering poly(ADP-ribose) polymerase-1-induced cell death (parthanatos). Cell Signal (2013) 0.89
Hypoxia-inducible factor-1α in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation. Circ Res (2013) 0.89
Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. J Heart Lung Transplant (2004) 0.88
Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail (2009) 0.88
Outcomes of children following a first hospitalization for dilated cardiomyopathy. Circ Heart Fail (2012) 0.87
Association of genetic polymorphisms and risk of late post-transplantation infection in pediatric heart recipients. J Heart Lung Transplant (2010) 0.86
Sacrificial layer technique for axial force post assay of immature cardiomyocytes. Biomed Microdevices (2013) 0.86
Homoplastic microinversions and the avian tree of life. BMC Evol Biol (2011) 0.86
Characterization of reference genes for quantitative real-time PCR analysis in various tissues of Anoectochilus roxburghii. Mol Biol Rep (2011) 0.85
Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. J Mol Cell Cardiol (2006) 0.85
β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways. J Mol Cell Cardiol (2011) 0.85
Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study. Transplantation (2011) 0.85
Brg1 governs distinct pathways to direct multiple aspects of mammalian neural crest cell development. Proc Natl Acad Sci U S A (2013) 0.85
Performing the synthesis of a complex molecule on sequentially linked columns: toward the development of a "synthesis machine". Org Lett (2005) 0.85
Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol (2011) 0.85
Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am J Physiol Heart Circ Physiol (2013) 0.85
Protective effect of Homer 1a against hydrogen peroxide-induced oxidative stress in PC12 cells. Free Radic Res (2012) 0.84
The lateral cutaneous nerve of the calf revisited. PM R (2010) 0.83
SERPINE1 expression discriminates site-specific metastasis in human melanoma. Exp Dermatol (2012) 0.83
A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. J Mater Sci Mater Med (2011) 0.83
Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol (2013) 0.83
Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.83
HLA desensitization with bortezomib in a highly sensitized pediatric patient. Pediatr Transplant (2014) 0.82
Inlet patch: heterotopic gastric mucosa--another contributor to supraesophageal symptoms? J Pediatr (2005) 0.82
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience. Circ Heart Fail (2010) 0.82
Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab. Transplantation (2005) 0.82
Dynamic localization and functional implications of C-peptide might for suppression of iNOS in high glucose-stimulated rat mesangial cells. Mol Cell Endocrinol (2013) 0.82
Use of the Impella 5.0 as a bridge from ECMO to implantation of the HeartMate II left ventricular assist device in a pediatric patient. Pediatr Transplant (2011) 0.81
The phylogenetic position of some Philippine "babblers" spans the muscicapoid and sylvioid bird radiations. Mol Phylogenet Evol (2012) 0.81
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models. J Med Chem (2012) 0.81
Hypercholesterolemia impairs exercise capacity in mice. Vasc Med (2009) 0.81
Orthotopic heart transplantation in two infants with histiocytoid cardiomyopathy and left ventricular non-compaction. Pediatr Transplant (2013) 0.81
Evaluation of the efficacy, toxicity and safety of vinorelbine incorporated in a lipid emulsion. Int J Pharm (2011) 0.81
Quick and highly efficient copper-catalyzed cycloaddition of organic azides with terminal alkynes. Org Biomol Chem (2011) 0.80
C-reactive protein induces interleukin-6 and thrombospondin-1 protein and mRNA expression through activation of nuclear factor-ĸB in HK-2 cells. Kidney Blood Press Res (2012) 0.80